At Balanced Aesthetics + Wellness, each therapy is prescribed only after clinical evaluation, baseline lab review, and individualized dosing design to ensure optimal safety and effectiveness
Retatrutide, an investigational triple GIP/GLP-1/glucagon receptor agonist developed by Eli Lilly, demonstrated unprecedented weight loss in Phase 2 trials but has not yet completed Phase 3 development
Semaglutide Injection bulk pricing & minimum order quantity (MOQ) structure Oddway International supports bulk procurement models that fit both routine wholesale and project-based institutional demand
Medical oversight ensures safe dosing and personalized care.
Martinez, C., Rodriguez, P., & Thompson, L